The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report

BACKGROUND: So far there has been little evidence on the antithrombotic treatment of patients presenting with atrial fibrillation (AF) and a CHA(2)DS(2)-VASc score of 1 in men (2 in women). However, a recently published position paper suggests a personalized approach in weighing individual risk fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammer, Andreas, Schnaubelt, Sebastian, Niessner, Alexander, Sulzgruber, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649479/
https://www.ncbi.nlm.nih.gov/pubmed/33204971
http://dx.doi.org/10.1093/ehjcr/ytaa176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649479/
https://www.ncbi.nlm.nih.gov/pubmed/33204971
http://dx.doi.org/10.1093/ehjcr/ytaa176

Ejemplares similares